REGN - Fibonacci Retracement 4 hr chartI've opened May 345 / June 340 Call Diagonal Spread.Longby SubGeniusUpdated 1
$REGN Difficult to be bullish on Regeneron Pharma Inc. Regeneron is just another victim of the outflows from healthcare, there is nothing positive to cling to on the chart. As earnings approaches price action can only indicate that more selling is imminent, short for now and look for long on test of support or trend line. Shortby RedHotStocks5
FDA approves Dupixent® (dupilumab) for moderate-to-severe atopicREGN: Regeneron Pharmaceuticals, Inc. 2019-03-11 15:44:00 FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents - PR NewswireLongby RocketTickers0
$REGN Potential problem potential mini H&S developing on the daily near top of trend line. MACD suggest not enough strength to break TL. Watching for a break of the neckline. by Hearsjonny0
$REGN Short swing Previous channel resistance, i can't help but think this will retest 400 and the 50 ema on daily. Shortby Hearsjonny3
Short REGN (Once 340 confirms a break)Watch very congested area at 340, short it once that is broken. Shortby KeyTrade4
Short REGN from 365 (Potential bounce)to 183Potential bounce to 365 area before falling again, target price at 183Shortby KeyTrade4
Really beautiful buying setup - REGNWill wait patiently for REGN to get into the buying box -- expect it to arrive last augustLongby AstatineUpdated 1
[REGN] phase 1 -> phase 2The price is above 30MM, the slope of 30MM is positive! If the price breaks the resistant, It will be in phase 2. But if you take risks, maybe you should buy!Longby jlaracena1
Waiting for a short on REGNHi, I am back proposing some ideas. Good trade to all ! Olive_bcShortby Olivier_bc2
REGN Short Play - Negative Divergence and Fib resistanceREGN hitting some resistance here and negative divergence on the RSI. Inside bar with closed with a doji today. Shortby ashwinpv9Updated 3
$REGN 50d/200d Golden Cross$REGN Regeneron Pharma - 50d/200d ema Golden Cross on the daily chart last week after a solid earnings report in early August. Assuming bullish trend line holds, expecting continued gains over the next couple months. Near term target - $391 (gap fill) Medium term target - $420 Longby Triple_Barrel_Capital3
FDA Approves EYLEA® (aflibercept) Injection sBLAREGN: Regeneron Pharmaceuticals, Inc. 2018-08-17 07:00:00 FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular DegenerationLongby RocketTickers2
Regeneron and Teva Announce Positive Topline Phase 3TEVA: Teva Pharmaceutical Industries Ltd. 2018-08-16 07:00:00 Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or HipLongby RocketTickers1
REGN- Slowly Bleeding to Death.....CURE TO COMETaking a quick look at the chart and analyzing volume, one can easily see the turnaround is soon to come. Look for a consistent price turnaround in the month of July (2018). The confirmed turnaround should occur early-mid August (2018). What do I know right???Longby hesswg48Updated 0
REGN: CHANGE IN TRENDIt seems the stock is changing the trend and may have bottomed out. Please ignore my previous post as targets were not correct.Longby FX0082
REGN- possible change in the trend.It seems the stock is changing the trend and may have bottomed out.Longby FX0081